The feasibility of triggers for the integration of Standardised, Early Palliative (STEP) Care in advanced cancer: A phase II trial
- PMID: 36185312
- PMCID: PMC9520487
- DOI: 10.3389/fonc.2022.991843
The feasibility of triggers for the integration of Standardised, Early Palliative (STEP) Care in advanced cancer: A phase II trial
Abstract
Background: While multiple clinical trials have demonstrated benefits of early palliative care for people with cancer, access to these services is frequently very late if at all. Establishing evidence-based, disease-specific 'triggers' or times for the routine integration of early palliative care may address this evidence-practice gap.
Aim: To test the feasibility of using defined triggers for the integration of standardised, early palliative (STEP) care across three advanced cancers.
Method: Phase II, multi-site, open-label, parallel-arm, randomised trial of usual best practice cancer care +/- STEP Care conducted in four metropolitan tertiary cancer services in Melbourne, Australia in patients with advanced breast, prostate and brain cancer. The primary outcome was the feasibility of using triggers for times of integration of STEP Care, defined as enrolment of at least 30 patients per cancer in 24 months. Triggers were based on hospital admission with metastatic disease (for breast and prostate cancer), or development of disease recurrence (for brain tumour cohort). A mixed method study design was employed to understand issues of feasibility and acceptability underpinning trigger points.
Results: The triggers underpinning times for the integration of STEP care were shown to be feasible for brain but not breast or prostate cancers, with enrolment of 49, 6 and 10 patients across the three disease groups respectively. The varied feasibility across these cancer groups suggested some important characteristics of triggers which may aid their utility in future work.
Conclusions: Achieving the implementation of early palliative care as a standardized component of quality care for all oncology patients will require further attention to defining triggers. Triggers which are 1) linked to objective points within the illness course (not dependent on recognition by individual clinicians), 2) Identifiable and visible (heralded through established service-level activities) and 3) Not reliant upon additional screening measures may enhance their feasibility.
Keywords: cancer; clinical trial, phase II; early palliative care; outpatient palliative care; personalized palliative care.
Copyright © 2022 Collins, Sundararajan, Le, Mileshkin, Hanson, Emery and Philip.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocol.Pilot Feasibility Stud. 2019 Mar 14;5:44. doi: 10.1186/s40814-019-0424-7. eCollection 2019. Pilot Feasibility Stud. 2019. PMID: 30915228 Free PMC article.
-
Care plus study: a multi-site implementation of early palliative care in routine practice to improve health outcomes and reduce hospital admissions for people with advanced cancer: a study protocol.BMC Health Serv Res. 2021 May 27;21(1):513. doi: 10.1186/s12913-021-06476-3. BMC Health Serv Res. 2021. PMID: 34044840 Free PMC article. Clinical Trial.
-
Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer.J Pain Symptom Manage. 2018 Aug;56(2):185-194. doi: 10.1016/j.jpainsymman.2018.03.022. Epub 2018 Mar 30. J Pain Symptom Manage. 2018. PMID: 29608934
-
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.Health Technol Assess. 2001;5(21):1-75. doi: 10.3310/hta5210. Health Technol Assess. 2001. PMID: 11532238 Review.
-
Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.Drugs R D. 2005;6(3):178-85. doi: 10.2165/00126839-200506030-00007. Drugs R D. 2005. PMID: 15869322 Review.
Cited by
-
Timing Matters: A Systematic Review of Early Versus Delayed Palliative Care in Advanced Cancer.Cancers (Basel). 2025 Aug 7;17(15):2598. doi: 10.3390/cancers17152598. Cancers (Basel). 2025. PMID: 40805293 Free PMC article. Review.
-
A Scoping Review of the Barriers and Facilitators to Clinician Engagement in Hospital-Based Palliative Care in Australian Hospitals.Am J Hosp Palliat Care. 2025 Aug;42(8):814-825. doi: 10.1177/10499091241287559. Epub 2024 Oct 1. Am J Hosp Palliat Care. 2025. PMID: 39352735 Free PMC article.
-
Integrated palliative care and oncology: a realist synthesis.BMC Med. 2025 May 9;23(1):272. doi: 10.1186/s12916-025-04083-1. BMC Med. 2025. PMID: 40346564 Free PMC article. Review.
-
Unscheduled hospitalization as a potential trigger for specialist palliative care referral in patients with high grade glioma: a retrospective analysis in a tertiary hospital.J Neurooncol. 2025 Jun;173(2):361-368. doi: 10.1007/s11060-025-04993-3. Epub 2025 Mar 6. J Neurooncol. 2025. PMID: 40048038
References
-
- Hwang SS, Chang VT, Cogswell J, Alejandro Y, Osenenko P, Morales E, et al. . Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model. J Pain Symptom Manage (2004) 28(5):421–32. doi: 10.1016/j.jpainsymman.2004.02.023 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous